论文部分内容阅读
营养性贫血是小儿常见病,我国7岁以下儿童的患病率高达90%左右,其中以铁质缺乏、血红蛋白生成不足引起的贫血最多见。以往临床上多以铁剂如硫酸亚铁、杨椽酸铁胺等进行治疗,虽有一定疗效,但服用后因对患儿胃肠道刺激较大。我们于1991年采用中国人民解放军101医院研制的生血素口服液治疗小儿贫血,经数月随访效果良好,治疗组患儿10名,每人每月口服10ml(1支),40天为一疗程;同时对对照组的10名患儿进行未治观察。三个月后随访,治疗组血色素平均升高2.9g/dl,体重平均增加0.73kg,身高平均增长2.6cm;对照组的血色素、体重及身高平均增长值分别为0.87g/dl、0.48kg和1.04cm.经统计学处理P<0.01,有显著差异.治疗
Nutritional anemia is a common disease in children, the prevalence of children under 7 years old in China as high as 90%, of which iron deficiency, anemia caused by the lack of hemoglobin is the most common. In the past, many patients with iron such as ferrous sulfate, acid ammonium ferricyanide and other treatment, although a certain effect, but after taking the gastrointestinal tract stimulation of children larger. In 1991, we used Shengshengsu Oral Liquid developed by People’s Liberation Army 101 Hospital to treat pediatric anemia. After several months of follow-up, we achieved good results. Ten children in the treatment group were orally administered with 10ml per person per day for 40 days At the same time, 10 children in the control group were not observed. After three months’ follow-up, the hemoglobin of the treatment group was increased by 2.9g / dl on average, the average body weight was increased by 0.73kg and the average height was 2.6cm. The mean hemoglobin, body weight and height of the control group were 0.87g / dl, 0.48kg and 1.04cm. Statistical analysis of P <0.01, there are significant differences in treatment